DI SEBASTIANO, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 4.414
EU - Europa 2.672
AS - Asia 2.301
SA - Sud America 397
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 9.836
Nazione #
US - Stati Uniti d'America 4.347
SG - Singapore 1.138
CN - Cina 621
IE - Irlanda 486
IT - Italia 403
BR - Brasile 340
SE - Svezia 335
UA - Ucraina 335
DE - Germania 320
GB - Regno Unito 267
TR - Turchia 179
FR - Francia 133
VN - Vietnam 120
FI - Finlandia 117
IN - India 100
RU - Federazione Russa 92
CA - Canada 37
AT - Austria 36
AR - Argentina 28
PL - Polonia 27
BD - Bangladesh 22
BE - Belgio 22
HK - Hong Kong 22
JP - Giappone 21
MX - Messico 21
NL - Olanda 21
ZA - Sudafrica 18
CZ - Repubblica Ceca 15
ES - Italia 15
IQ - Iraq 11
KR - Corea 10
CO - Colombia 8
IL - Israele 8
EU - Europa 7
LT - Lituania 7
PK - Pakistan 7
GR - Grecia 6
MA - Marocco 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EC - Ecuador 5
EE - Estonia 5
ID - Indonesia 5
BG - Bulgaria 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
PY - Paraguay 4
VE - Venezuela 4
AO - Angola 3
AZ - Azerbaigian 3
EG - Egitto 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
UY - Uruguay 3
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
GL - Groenlandia 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BT - Bhutan 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.836
Città #
Singapore 849
Chandler 842
Dublin 481
Jacksonville 461
Ashburn 342
Dallas 261
Princeton 224
Beijing 211
Southend 157
Munich 131
Wilmington 121
Los Angeles 119
Santa Clara 107
Izmir 93
Nanjing 83
Chieti 82
Dearborn 75
Altamura 72
The Dalles 67
New York 60
Helsinki 57
Cambridge 52
Washington 49
Ann Arbor 46
Buffalo 46
Tongling 45
Boardman 40
Redondo Beach 38
Ho Chi Minh City 36
Woodbridge 34
Hanoi 31
Pescara 31
Council Bluffs 27
Moscow 27
Vienna 27
Hefei 26
São Paulo 26
Houston 25
Warsaw 24
Denver 23
Brussels 22
Hong Kong 22
Nanchang 22
Tokyo 20
Brooklyn 19
Nuremberg 19
Boston 18
Montreal 17
Chicago 16
Dong Ket 16
Falls Church 16
Rome 16
Shenyang 16
London 15
Stockholm 14
Tianjin 14
Brno 13
Frankfurt am Main 13
Johannesburg 13
San Francisco 13
Seattle 13
Amsterdam 12
Edinburgh 12
Kunming 12
Chennai 11
Grevenbroich 11
Pune 11
Rio de Janeiro 11
Vittuone 11
Atlanta 10
Jiaxing 10
Manchester 10
Orem 10
Poplar 10
Seoul 10
Toronto 10
Hebei 9
Norwalk 9
Phoenix 9
Brasília 8
Charlotte 8
Istanbul 8
Belo Horizonte 7
Fairfield 7
Milan 7
Turku 7
Ancona 6
Campinas 6
Changsha 6
Curitiba 6
Guangzhou 6
Mexico City 6
Redmond 6
Saint Louis 6
São José dos Campos 6
West Jordan 6
Arcore 5
Baghdad 5
Bologna 5
Columbus 5
Totale 6.215
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 251
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 182
Totally laparoscopic complete mesocolon excision for splenic flexure cancer. A single institution experience 144
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 139
MICROSATELLITE ALTERATIONS IN PANCREATIC CARCINOMA 131
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 131
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 130
Batimastat, A Matrix Metalloproyeinase inhibitor accellerates Healing in Rat Experimental Colitis 129
[Laparoscopic adrenalectomy: analysis of 65 cases] 129
Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis 128
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells 128
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 123
[Carcinoma of the male breast. Our experience]. 122
Beneficial Effects of Batimastat (bb-94), a Matrix Metalloproteinase Inhibitor, in Rat Experimental Colitis 121
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 117
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 116
Extracorporeal versus intracorporeal anastomosis after laparoscopic right hemicolectomy: cost-effectiveness analysis 115
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 114
A modified fast-track program for pancreatic surgery: A prospective single-center experience 114
Totally laparoscopic complete mesocolon excision for splenic flexure cancer 113
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 111
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 109
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 109
Appendicitis: the role of nerves in pain generation 106
A surgical department for intensified care 105
Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients 104
A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable 101
The Pituitary Adenylate Cyclase-Activating Polypeptide Pathway is Activated in Human Chronic Pancreatitis. 100
Espressione del Connective Tissue Growth Factor (CTGF) nel cancro pancreatico 98
Time-qualified patterns of variation of PPAR γ, DNMT1, and DNMT3B expression in pancreatic cancer cell lines 96
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: A meta-analysis of prospective studies 96
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis 96
Endoscopic therapy for type B surgical biliary injury in a patient with short cystic duct. 94
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. 94
Influenza dei neurotrasmettitori algogeni sulla crescita cellulare nel cancro del pancreas 93
Combined therapy in pancreatic cancer 91
Alterations of dna-repeats in pancreatic cancer 91
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 91
Alterations of dna-repeats in pancreatic cancer 91
Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers 90
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy 88
Mirna expression profiles identify drivers in colorectal and pancreatic cancers 88
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis 87
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients 86
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 86
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 86
Haemorrhoids and transient receptor potential vanilloid 1 86
TRANSFORMING GROWTH FACTOR-BETA PATHWAY IS ACTIVATED IN CHOLECYSTOLITHIASIS 85
How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer 85
Cathepsins and pancreatic cancer: The 2012 update. 84
Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer 84
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients 83
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 82
Mechanism of pain in chronic pancreatitis 81
PI3K-gamma upregulation promotes proliferation and AKT activation in pancreatic cancer 81
Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation 81
Determinant-based classification of acute pancreatitis severity: International multidisciplinary classification of acute pancreatitis severity: The 2013 German Edition [Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013] 81
Laparoscopic Versus Open Hartmann Reversal: A Case-Control Study 80
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 80
Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks 80
Differential expression of connective tissue growth factor in inflammatory bowel disease. 79
Expression of interleukin-8 and substance P in human chronic pancreatitis 79
Pathogenesis of pain in chronic pancreatitis 79
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: Single centre experience 79
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly 78
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma 78
The techniques of duodenum preserving head resection of the pancreas in the treatment of chronic pancreatitis 78
Mapping of Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer 77
Changes in cytokine but not tachynin gene expression in patients with chronic pancreatitis 77
Support vector machine based on microRNA expression profiles to predict histological origin of ampullary carcinoma case report of a patient affected from adenocarcinoma of the papilla of vater with lynch syndrome 77
Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction 77
Substance P and neprilysin in chronic pancreatitis 77
The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification? 77
International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition 76
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management 76
Desmoplastic reaction influences pancreatic cancer growth behavior 75
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial 75
Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease 75
Chemokine receptor CXCR4: Role in gastrointestinal cancer 74
Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease 74
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases 74
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation 73
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. 72
Neuroimmune appendicitis: a new pathological entity? 72
Italian consensus guidelines for chronic pancreatitis 72
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis 72
Key Role of Phosphoinositide 3-kinase Class IB in Pancreatic Cancer. 71
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix 70
Combined modality treatments in pancreatic cancer 69
Phosphoinositide 3-Kinase Class IB plays a key role in human pancreatic cancer 67
Cronic pancreatitis: evidence for neurogenic inflammation 67
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis 67
Immune cell infiltration and Growth associated protein-43 correlate with pain in chronic pancreatitis. 66
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels 66
Immune cells infiltration and the expression of growth associated protein-43 expression correlate with pain in chronic pancreatisis 65
Phosphatidylserine receptor in chronic pancreatitis: Evidence for a macrophage independent role 65
The neuroimmune connection in chronic pancreatisis 64
Re: Red hot chilli consumption is harmful in patients operated for anal fissure - A randomized, double-blind, controlled study 64
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 64
Key role of Phosphoinositide 3-Kinase Class IB in pancreatic cancer 61
Totale 9.215
Categoria #
all - tutte 45.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 165 20 18 38 91 16 41
2021/2022595 25 28 16 99 32 10 4 38 36 5 73 229
2022/20232.049 200 312 123 269 143 366 99 183 220 24 76 34
2023/2024904 58 35 81 26 80 300 157 58 1 33 6 69
2024/20252.106 114 349 239 81 65 117 125 140 269 81 248 278
2025/20262.012 368 172 461 471 498 42 0 0 0 0 0 0
Totale 10.341